ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → n-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1h-indazol-1-yl)methyl]phenyl}methyl)-3-morpholinecarboxamide formate salt

HRID 1874723
印刷

反応式

HRID 1874723 の反応式
[N:1]1([O:10][C:11](N(C)C)=[N+](C)C)[C:5]2[N:6]=[CH:7][CH:8]=[CH:9][C:4]=2N=[N:2]1.F[P-](F)(F)(F)(F)F.C([O:29]C([N:32]1[CH2:37][CH2:36][O:35][CH2:34][CH:33]1[C:38]([OH:40])=O)=O)(C)(C)C.[CH:41](N(CC)C(C)C)([CH3:43])[CH3:42].C(O)=O.NCC1C=C(CN2[C:70]3[C:65](=[C:66]([OH:71])[CH:67]=[CH:68][CH:69]=3)[C:64]([NH:72][S:73]([C:76]3[S:77][C:78]([Cl:81])=[CH:79][CH:80]=3)(=[O:75])=[O:74])=N2)C=CC=1.ClC1SC(S(NC2C3C(=CC=CC=3O)N(CC3C=C(CNC(C4COCCN4C(OC(C)(C)C)=O)=O)C=CC=3)N=2)(=O)=O)=CC=1.Cl.O1CCOCC1>CN(C=O)C.ClCCl.CO>[CH:11]([OH:10])=[O:29].[Cl:81][C:78]1[S:77][C:76]([S:73]([NH:72][C:64]2[C:65]3[C:70](=[CH:69][CH:68]=[CH:67][C:66]=3[OH:71])[N:1]([CH2:5][C:4]3[CH:9]=[C:8]([CH2:7][NH:6][C:38]([CH:33]4[CH2:34][O:35][CH2:36][CH2:37][NH:32]4)=[O:40])[CH:42]=[CH:41][CH:43]=3)[N:2]=2)(=[O:75])=[O:74])=[CH:80][CH:79]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

11

反応物 7

HCID 313Hydrochloric Acid3 回HCID 312751,4-DioxaneHCID 81531DiisopropylethylamineHCID 27601334-(tert-Butoxycarbonyl)morpholine-3-carboxylic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)
HCID 136346357
n-(1-{[3-(Aminomethyl)phenyl]methyl}-4-hydroxy-1h-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt
HCID 1363463601,1-dimethylethyl 3-{[({3-[(3-{[(5-chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)amino]carbonyl}-4-morpholinecarboxylate

生成物 1

HCID 136346359n-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1h-indazol-1-yl)methyl]phenyl}methyl)-3-morpholinecarboxamide formate salt収率 43%

試薬・触媒・溶媒 3

HCID 887Methanol溶媒2 回HCID 6228Dimethylformamide溶媒2 回HCID 6344Dichloromethane溶媒

実験手順

To a solution of O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (43.8 mg, 0.071 mmol) in anhydrous DMF (1 mL) was added at room temperature morpholine-3,4-dicarboxylic acid 4-tert-butyl ester (Fluorochem) (14.95 mg, 0.065 mmol) followed by N,N-diisopropylethylamine (0.034 ml, 0.19 mmol) and finally a solution of N-(1-{[3-(aminomethyl)phenyl]methyl}-4-hydroxy-1H-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt (for a preparation see Intermediate 15) (32 mg, 0.065 mmol) in anhydrous DMF (1 mL) and the reaction mixture was stirred at room temperature for 30 min. The reaction mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate. The organic layer was separated, washed with brine-water (1:1), passed through a hydrophobic frit, and evaporated in-vacuo to yield a colourless oil. LCMS (System B) RT=2.91 min, ES+ve m/z 662/664 (M+H)+ for 1,1-dimethylethyl 3-{[({3-[(3-{[(5-chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)amino]carbonyl}-4-morpholinecarboxylate. This was suspended in anhydrous dichloromethane (2 mL) and treated with a solution of hydrogen chloride in 1,4-dioxane (4M, 0.162 mL, 0.646 mmol). The reaction mixture was still a suspension, therefore methanol was added dropwise until the reaction was in solution. The mixture was stirred at room temperature for 1 hour, and a further portion of hydrogen chloride solution (4M, 0.162 mL) was added to the reaction mixture and stirred for 90 min. Yet another portion of hydrogen chloride solution (4M, 0.162 mL) was added to the reaction mixture and stirred for 90 min. The reaction mixture was evaporated in-vacuo to yield a colourless oil. The residual oil was dissolved in MeOH:DMSO (1 mL) and purified by MDAP Sunfire C18 column, eluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B: 0.1% v/v solution of formic acid in acetonitrile) (25 min run). Appropriate fractions were combined and evaporated in-vacuo to yield the title compound as a colourless oil (17 mg, 43%). LCMS (System B) RT=1.62 min, ES+ve m/z 562/564 (M+H)+.

後処理

  1. customThe reaction mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate
  2. customThe organic layer was separated
  3. washwashed with brine-water (1:1)
  4. customevaporated in-vacuo
  5. customto yield a colourless oil
  6. stirringThe mixture was stirred at room temperature for 1 hour
  7. stirringstirred for 90 min
  8. stirringstirred for 90 min
  9. customThe reaction mixture was evaporated in-vacuo
  10. customto yield a colourless oil
  11. customDMSO (1 mL) and purified by MDAP Sunfire C18 column
  12. washeluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B
  13. custom(25 min run)
  14. customevaporated in-vacuo

出典と根拠

ORDレコード
ord-f7f122484bae4ed38f4029f958a1d01c
出典データセット
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08304446B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート